ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.163,88
0,53%
S&P 500
5.487,03
0,25%
Dow Jones
38.834,86
0,15%
Euro vs US Dollar
1,07292
-0,17%
Bitcoin
66.390,96
2,19%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Interpace Biosciences Inc (QX) (IDXG)

  7. Interpace Biosciences Inc (QX) (IDXG) News

IDXG

Interpace Biosciences (QX) (IDXG)

Interpace Biosciences Inc (QX)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:IDXG
DatumZeitQuelleÜberschriftSymbolFirma
09/05/202422h29Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IDXGInterpace Biosciences Inc (QX)
12/02/202423h01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:IDXGInterpace Biosciences Inc (QX)
06/02/202412h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:IDXGInterpace Biosciences Inc (QX)
12/12/202322h05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IDXGInterpace Biosciences Inc (QX)
16/11/202322h05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IDXGInterpace Biosciences Inc (QX)
08/11/202323h14Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IDXGInterpace Biosciences Inc (QX)
08/11/202322h16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:IDXGInterpace Biosciences Inc (QX)
27/10/202322h05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IDXGInterpace Biosciences Inc (QX)
22/09/202322h53Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialUSOTC:IDXGInterpace Biosciences Inc (QX)
22/09/202322h20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsUSOTC:IDXGInterpace Biosciences Inc (QX)
09/08/202321h47Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IDXGInterpace Biosciences Inc (QX)
09/08/202319h27Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:IDXGInterpace Biosciences Inc (QX)
01/08/202323h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:IDXGInterpace Biosciences Inc (QX)
12/05/202322h35Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IDXGInterpace Biosciences Inc (QX)
12/05/202322h24Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IDXGInterpace Biosciences Inc (QX)
03/05/202321h17Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:IDXGInterpace Biosciences Inc (QX)
28/04/202322h20Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:IDXGInterpace Biosciences Inc (QX)
27/03/202322h43Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IDXGInterpace Biosciences Inc (QX)
27/03/202322h40Edgar (US Regulatory)Annual Report (10-k)USOTC:IDXGInterpace Biosciences Inc (QX)
14/11/202223h28Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IDXGInterpace Biosciences Inc (QX)
14/11/202223h25Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IDXGInterpace Biosciences Inc (QX)
04/11/202221h34Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IDXGInterpace Biosciences Inc (QX)
04/10/202222h20Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IDXGInterpace Biosciences Inc (QX)
20/09/202222h47Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:IDXGInterpace Biosciences Inc (QX)
20/09/202222h37Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:IDXGInterpace Biosciences Inc (QX)
09/09/202222h29Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:IDXGInterpace Biosciences Inc (QX)
07/09/202222h46Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IDXGInterpace Biosciences Inc (QX)
15/08/202223h46Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IDXGInterpace Biosciences Inc (QX)
16/05/202223h02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IDXGInterpace Biosciences Inc (QX)
16/05/202222h51Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IDXGInterpace Biosciences Inc (QX)
 Showing the most relevant articles for your search:USOTC:IDXG

Kürzlich von Ihnen besucht

TSXV
CSG.H
Cosigo Resources
NASDAQ
CWACX
First Trust Managed Muni...
USOTC
SKYED
Skye Bioscience (QB)
NASDAQ
ECDA
ECD Automotive Design
EU
CDCHA
Caisse Depots Et Consign...
EU
FR001400OGI0
BPCE Bpce Frn 06mar2026
BIT
P1ENK5
BNP Paribas Issuance
COIN
FRSPGBP
SUSHI
LINKETH
ChainLink Token
COIN
SAMAUSD
SAMA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten